Bariatric Surgery and Gut Microbiota Changes Over Time
Official title: Longitudinal Evaluation of Gut Microbiota and Fecal Metabolome Following Roux-en-Y Gastric Bypass: Clinical Implications and Identification of Predictive Biomarkers
Run by Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis · NCT07381140 · Data updated 2026-11-12
This study looks at how gut bacteria and stool metabolites change over 12 months after Roux-en-Y gastric bypass in adults with obesity, compared with those treated with diet alone and healthy-weight individuals.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis Academic / other |
| Locations | 1 site (Castellana Grotte, BA) |
| Status | Recruiting |
| Started | July 7, 2026 |
| Main results expected | April 2027 |
| Study ends | April 2028 |
| Registry record updated | November 5, 2026 |
| Trial ID | NCT07381140 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–65 with obesity undergoing RYGB, or adults with obesity treated with diet alone, and healthy adults with normal weight.
✕Probably not a fit
Patients who are not undergoing bariatric surgery or do not fit the specified BMI or health criteria may not experience the suggested insights.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective observational study will follow adults aged 18 to 65 who are undergoing Roux-en-Y gastric bypass, along with a control group of adults with obesity managed by diet and a healthy normal-weight group. Researchers will collect stool samples and blood at multiple time points over 12 months to analyze gut microbiota composition and fecal metabolome, and relate these findings to weight loss and metabolic outcomes. The goal is to understand the timing, persistence, and clinical relevance of microbial and metabolic changes after bariatric surgery compared with weight-loss by diet alone and with normal weight. The study does not involve an intervention beyond standard clinical care and data collection, and eligibility is limited to specified BMI ranges and health statuses. Interventions are not specified beyond observational data collection.
Why it matters
Potential benefit: If successful, the study could clarify how bariatric surgery reshapes the gut ecosystem and whether these changes relate to improved metabolic health.
How similar studies have gone: Previous observational work suggests gut microbiota can change after bariatric procedures, but longitudinal links to clinical outcomes remain to be clarified in this comparator design.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria (RYGB Group): * Age between 18 and 65 years. * Adults with a body mass index (BMI) ≥ 35 kg/m² with related comorbidities, or BMI ≥ 40 kg/m², who are candidates for Roux-en-Y gastric bypass (RYGB) surgery only. Exclusion Criteria (RYGB Group): * Treatment with antibiotics within the last 3 weeks, or probiotics/prebiotics within the last 4-6 weeks, or systemic corticosteroids within the 8 weeks prior to baseline (T0). * Participation in dietary regimens or calorie restriction programs in the weeks prior to enrollment. * Chronic inflammatory bowel diseases (e.g., Crohn's disease, ulcerative colitis), ongoing enteric infections, or active neoplasms. * Previous organ transplant or ongoing systemic immunosuppressive therapy. * Pregnancy or breastfeeding. * Previous major gastrointestinal surgery. * Chronic alcohol consumption above moderate levels or substance use disorder. Inclusion Criteria (Obese Control Group): * Age between 18 and 65 years. * Adults with BMI ≥ 30 kg/m² who are candidates for structured dietary treatment. Inclusion Criteria (Healthy Control Group): * Age between 18 and 65 years. * Normal weight (BMI between 18.5 and 24.9 kg/m²). * Normal metabolic function: fasting glucose below threshold, normal ALT/AST, no diagnosis of diabetes or metabolic syndrome. * No chronic gastrointestinal diseases or conditions that could alter the gut microbiota. Exclusion Criteria (Obese Control and Healthy Control Group): * Use of antibiotics within the last 3 weeks or probiotics/prebiotics within the last 4-6 weeks. * Recent gastrointestinal surgery. * Pregnancy or breastfeeding. * Extreme diets or recent dietary changes. * Recent international travel that could have affected the gut microbiota. * Medications known to influence the gut microbiota (e.g., PPIs, metformin, steroids). * Active smoking or excessive alcohol consumption. * Significant gastrointestinal symptoms (chronic diarrhea or constipation).
Where it's running
-
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
Castellana Grotte, Ba, Italy Recruiting
Study contacts
- Study coordinator: Domenica Mallardi, Biologist
- Email: domenica.mallardi@irccsdebellis.it
- Phone: +390804994129
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Optimized Flow for Obese Patients Undergoing Heart Surgery
In this study, researchers will test whether using ideal body weight to set cardiopulmonary bypass flow during heart surgery helps obese adults see fewer transfusions and related complications.
-
Overnight Temperature Regulation to Test Gut Health, Inflammation, and Circadian Rhythms
This study tests whether two weeks of using the Eight Sleep Pod at night can improve gut bacteria balance, lower inflammation, and strengthen daily temperature and blood pressure rhythms in postmenopausal women and age-matched men with poor sleep.
-
External Oblique Intercostal Block With or Without Lidocaine for Pain After Gastric Bypass
This study tests whether adding a lidocaine IV infusion to a bilateral EOIB with low-dose fentanyl helps manage pain during gastric bypass in obese adults.
-
Probiotic Y7 cocktail to help with early Parkinson’s symptoms
A 12-week randomized trial will test whether a probiotic Y7 cocktail helps people with early Parkinson’s disease by possibly improving motor, thinking, and everyday symptoms.
-
Novel functional snack and perimenopause: does a fibre- and phytochemical-rich bite help symptoms?
A daily snack enriched with phytochemicals and fiber is being tested to see if it can reduce perimenopausal symptoms and improve well-being in women aged 40–55 who are not using hormone therapy.
-
Dairy versus plant-based yogurt effects on weight, muscle, bones, and gut bacteria
This study will test whether eating dairy yogurt instead of a plant-based yogurt (or no yogurt) helps postmenopausal women with overweight or obesity maintain muscle and bone health, control weight, and change gut bacteria.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.